3D Systems (DDD) news

Collplant Biotechnologies - To use proceeds to accelerate Lightsolver R&D programs

CollPlant Biotechnologies (NASDAQ: CLGN) has announced plans to allocate a portion of its recent capital proceeds to accelerate the research and development (R&D) programs of its newly acquired subsidiary, LightSolver. This strategic move aims to enhance CollPlant’s capabilities in photonic…

Collplant Biotechnologies - Unit files U.S. provisional patent application expanding photonic computing platform

CollPlant Biotechnologies, a regenerative and aesthetic medicine company, has filed a U.S. provisional patent application that expands its photonic computing platform, signaling continued innovation in its 3D bioprinting and tissue engineering technologies. The filing is part of the company’s…

6K Additive - Agreement valued at $8.1 mln minimum, $10.8 mln maximum over 30 months

6K Additive has entered into a supply agreement with 3D Systems for tungsten powder, valued at a minimum of $8.1 million and a maximum of $10.8 million over a 30-month period. Under the agreement, 6K Additive will serve as the preferred supplier of tungsten powder for 3D Systems’ Direct Metal…

3D Systems receives $9M contract award from U.S. Air Force

3D Systems Corp CEO Dr. Jeffrey A. Graves to step down

3D Systems Corp (NYSE: DDD) announced on August 4, 2026, that Dr. Jeffrey A. Graves will step down as President and Chief Executive Officer and retire from the Board of Directors. Dr. Graves will remain in his current role until a successor is appointed, which is expected to occur before the end of…